Djibouti vs Senegal: Cause of death, by non-communicable diseases, ages 60+, male
Djibouti
61.1%
in 2021
Senegal
61.4%
in 2021
Djibouti rank
131st
Senegal rank
129th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Djibouti
- Senegal
How they compare
Senegal currently reports 61.4% against 61.1% in Djibouti, a difference of 0.3%.
Across all 6 years both countries report, Senegal has been ahead every year.
Djibouti ranks 131st and Senegal ranks 129th of 185 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.6% | 69.0% | 12.4% | Senegal |
| 2010s | 67.4% | 74.8% | 7.4% | Senegal |
| 2020s | 64.5% | 66.4% | 1.9% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Djibouti or Senegal?
- Senegal, at 61.4% against 61.1% in Djibouti as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Djibouti and Senegal?
- 0.3%, with Senegal ahead.
- How many years of comparable data are there for Djibouti and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do Djibouti and Senegal rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Djibouti ranks 131st and Senegal ranks 129th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.